These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 24169237

  • 1. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA, Oliveira SM, Guido LF, Magalhães A, Valencia G, Arsequell G, Saraiva MJ, Cardoso I.
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [Abstract] [Full Text] [Related]

  • 2. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M, Silva SC, Santana I, Cardoso I.
    CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
    [Abstract] [Full Text] [Related]

  • 3. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease.
    Oliveira SM, Ribeiro CA, Cardoso I, Saraiva MJ.
    J Alzheimers Dis; 2011 Jul; 27(2):429-39. PubMed ID: 21841252
    [Abstract] [Full Text] [Related]

  • 4. Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study1.
    Rejc L, Gómez-Vallejo V, Rios X, Cossío U, Baz Z, Mujica E, Gião T, Cotrina EY, Jiménez-Barbero J, Quintana J, Arsequell G, Cardoso I, Llop J.
    J Alzheimers Dis; 2020 Jul; 77(1):99-112. PubMed ID: 32804152
    [Abstract] [Full Text] [Related]

  • 5. Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal.
    Gimeno A, Santos LM, Alemi M, Rivas J, Blasi D, Cotrina EY, Llop J, Valencia G, Cardoso I, Quintana J, Arsequell G, Jiménez-Barbero J.
    J Med Chem; 2017 Jul 13; 60(13):5749-5758. PubMed ID: 28587455
    [Abstract] [Full Text] [Related]

  • 6. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R.
    Neurodegener Dis; 2010 Jul 13; 7(1-3):88-95. PubMed ID: 20173334
    [Abstract] [Full Text] [Related]

  • 7. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD.
    Rios X, Gómez-Vallejo V, Martín A, Cossío U, Morcillo MÁ, Alemi M, Cardoso I, Quintana J, Jiménez-Barbero J, Cotrina EY, Valencia G, Arsequell G, Llop J.
    Sci Rep; 2019 Sep 20; 9(1):13672. PubMed ID: 31541162
    [Abstract] [Full Text] [Related]

  • 8. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S.
    Brain Pathol; 2009 Jan 20; 19(1):48-57. PubMed ID: 18429966
    [Abstract] [Full Text] [Related]

  • 9. Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery.
    Cotrina EY, Gimeno A, Llop J, Jiménez-Barbero J, Quintana J, Valencia G, Cardoso I, Prohens R, Arsequell G.
    J Med Chem; 2020 Mar 26; 63(6):3205-3214. PubMed ID: 32124607
    [Abstract] [Full Text] [Related]

  • 10. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Mar 26; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 12. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS.
    J Neurosci; 2007 Jun 27; 27(26):7006-10. PubMed ID: 17596449
    [Abstract] [Full Text] [Related]

  • 13. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi SH, Kang J, Kim HJ, Kwon SH, Jang CG, Lee JH, Kim HC, Nah SY.
    J Alzheimers Dis; 2012 Jun 27; 31(1):207-23. PubMed ID: 22543851
    [Abstract] [Full Text] [Related]

  • 14. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M.
    Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H, Yang H, Xie Z, Wang P, Bi J.
    Neurol Res; 2015 Jan 28; 37(1):84-91. PubMed ID: 25005263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.